RESISTENTIA PHARMACEUTICALS

resistentia-pharmaceuticals-logo

Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiple sclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.

#SimilarOrganizations #Financial #More

RESISTENTIA PHARMACEUTICALS

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
1998-01-01

Address:
Uppsala, Uppsala Lan, Sweden

Country:
Sweden

Status:
Active

Total Funding:
13.96 M USD


Similar Organizations

epicyte-pharmaceuticals-logo

Epicyte Pharmaceuticals

Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.

Investors List

innovations-kapital_image

Innovations Kapital

Innovations Kapital investment in Series C - Resistentia Pharmaceuticals

industrifonden_image

Industrifonden

Industrifonden investment in Series C - Resistentia Pharmaceuticals

gsk-venture-fund_image

GSK

GSK investment in Series C - Resistentia Pharmaceuticals

bankinvest-biomedical-venture_image

BankInvest Biomedical Venture

BankInvest Biomedical Venture investment in Series C - Resistentia Pharmaceuticals

healthcap_image

HealthCap

HealthCap investment in Series C - Resistentia Pharmaceuticals

More informations about "Resistentia Pharmaceuticals" on Search Engine